SCHEMBL29601159

SCHEMBL29601159

Cc1ccnc(C(=O)CBr)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.46
UHRF1 Q96T88 1/20 0.42
CCR1 P32246 1/20 0.42
CCR5 P51681 1/20 0.42
CCR8 P51685 1/20 0.42
CTSA P10619 2/20 0.41
PTGS2 P35354 8/20 0.40
PTGS1 P23219 6/20 0.40
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8119356 1.00 GSK3B (0.46) GSK3BUHRF1CCR1CCR5CCR8
Bromide SCHEMBL6173297 0.98 GSK3B (0.44) GSK3BUHRF1CCR1CCR5CCR8
Bromide SCHEMBL29601226 0.98 GSK3B (0.44) GSK3BUHRF1CCR1CCR5CCR8
Bromide SCHEMBL27039809 0.96 GSK3B (0.43) GSK3BUHRF1CCR1CCR5CCR8
SCHEMBL30885027 0.83 UHRF1 (0.43) UHRF1CCR1CCR5CCR8CTSA
SCHEMBL2643034 0.83 UHRF1 (0.43) UHRF1CCR1CCR5CCR8CTSA
SCHEMBL17820448 0.83 UHRF1 (0.43) UHRF1CCR1CCR5CCR8CTSA
Hydrochloric Acid SCHEMBL6788469 0.80 MEN1 (0.41) UHRF1CCR1CCR5CCR8CTSA
SCHEMBL15926105 0.80 CTSA (0.43) UHRF1CCR1CCR5CCR8CTSA
SCHEMBL2067966 0.80 GABRA1 (0.46) UHRF1CCR1CCR5CCR8CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 CN disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed